tiprankstipranks
Sinopharm Group Co Ltd Class H (SHTDF)
OTHER OTC:SHTDF
US Market
SHTDF
Sinopharm Group Co
RESEARCH TOOLSreports

Sinopharm Group Co (SHTDF) Stock News & Sentiment

59 Followers
Sinopharm Sets April Board Meeting to Approve First-Quarter 2026 Results
Premium
Company Announcements
Sinopharm Sets April Board Meeting to Approve First-Quarter 2026 Results
18h ago
Sinopharm Subsidiary Sinopharm Accord Posts Sharp 2025 Profit Rebound Despite Weaker Cash Flow
Premium
Company Announcements
Sinopharm Subsidiary Sinopharm Accord Posts Sharp 2025 Profit Rebound Despite Weaker Cash Flow
9d ago
Sinopharm Defies Industry Headwinds With 2025 Profit Growth and Retail Turnaround
Premium
Company Announcements
Sinopharm Defies Industry Headwinds With 2025 Profit Growth and Retail Turnaround
19d ago
Sinopharm Proposes Final Cash Dividend of RMB 0.69 per Share for 2025
Premium
Company Announcements
Sinopharm Proposes Final Cash Dividend of RMB 0.69 per Share for 2025
19d ago
Sinopharm Subsidiary Posts 2025 Revenue Growth Amid Flat Earnings and Stronger Cash Flow
Premium
Company Announcements
Sinopharm Subsidiary Posts 2025 Revenue Growth Amid Flat Earnings and Stronger Cash Flow
23d ago
Sinopharm Device Subsidiary Boosts Profit and Cash Flow Despite Lower 2025 Revenue
Premium
Company Announcements
Sinopharm Device Subsidiary Boosts Profit and Cash Flow Despite Lower 2025 Revenue
23d ago
Sinopharm Accord Posts Strong 2025 Profit Growth Despite Slight Revenue Dip
Premium
Company Announcements
Sinopharm Accord Posts Strong 2025 Profit Growth Despite Slight Revenue Dip
24d ago
More SHTDF News >

SHTDF News on the Web

Sinopharm Group Co (SHTDF) Gets a Buy from First Shanghai Securities
TipRanks News
Neutral
Sinopharm Subsidiary Sinopharm Accord Posts Sharp 2025 Profit Rebound Despite Weaker Cash Flow
TipRanks News
Neutral
Sinopharm Group Co (SHTDF) Receives a Buy from CICC
TipRanks News
Bullish
Daiwa Reaffirms Their Buy Rating on Sinopharm Group Co (SHTDF)
TipRanks News
Bullish
Huatai Securities Keeps Their Buy Rating on Sinopharm Group Co (SHTDF)
TipRanks News
Bullish
Citi Sticks to Their Buy Rating for Sinopharm Group Co (SHTDF)
TipRanks News
Bullish
Sinopharm Group Co (SHTDF) Gets a Hold from Goldman Sachs
TipRanks News
Neutral
UBS Keeps Their Buy Rating on Sinopharm Group Co (SHTDF)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
SHTDF
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.25 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SHTDF’s Media Buzz Sentiment?
1 articles about SHTDF were published this week. In an average week, 3.25 articles are published.
    What is SHTDF’s weekly average amount of articles?
    In an average week, 3.25 articles about SHTDF are published.
      What is SHTDF’s News Sentiment?
      50% of articles about SHTDF were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        STAAStaar Surgical
        AORTArtivion
        OWLTOwlet
        HUMHumana
        Showing the stocks with the most bullish news sentiment over the past week